(Q30412800)

21 June 2017

title

Safety and immunogenicity of multimeric-001--a novel universal influenza vaccine (English)

1 reference

21 June 2017

1 reference

Jacob Atsmon

1

1 reference

21 June 2017

Efrat Kate-Ilovitz

2

1 reference

21 June 2017

Dimitry Shaikevich

3

1 reference

21 June 2017

Yossi Singer

4

1 reference

21 June 2017

Inna Volokhov

5

1 reference

21 June 2017

Kirsten Y Haim

6

1 reference

21 June 2017

Tamar Ben-Yedidia

7

1 reference

21 June 2017

publication date

9 February 2012

1 reference

Journal of Clinical Immunology

21 June 2017

published in

1 reference

21 June 2017

volume

32

1 reference

21 June 2017

issue

3

1 reference

21 June 2017

page(s)

595-603

1 reference

https://scigraph.springernature.com/pub.10.1007/s10875-011-9632-5

21 June 2017

exact match

0 references

cites work

Antibody response to influenza vaccination in the elderly: a quantitative review

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9632-5

Current status of short synthetic peptides as vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9632-5

Design of peptide and polypeptide vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9632-5

Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9632-5

Synergistic effect of immunization with a peptide cocktail inducing antibody, helper and cytotoxic T-cell responses on protection against respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9632-5

Viral peptide immunogens: current challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9632-5

Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9632-5

Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9632-5

Peptide vaccines against hepatitis B virus: from animal model to human studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9632-5

New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9632-5

Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9632-5

Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9632-5

Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9632-5

Nanotechnology in vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9632-5

Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9632-5

HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9632-5

Cytotoxic lymphocytes and antibody-dependent complement-mediated cytotoxicity induced by administration of influenza vaccine

21 January 2018

1 reference

12 December 2020

Efficacy of anti-influenza peptide vaccine in aged mice

1 reference

12 December 2020

Exact prediction of a natural T cell epitope

1 reference

12 December 2020

Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model

1 reference

12 December 2020

10.1007/S10875-011-9632-5

Identifiers

DOI

1 reference

Dimensions Publication ID

21 June 2017

1048414733

0 references

1 reference